Online citations, reference lists, and bibliographies.

A Novel Algorithm For Reliable Detection Of Human Papillomavirus In Paraffin Embedded Head And Neck Cancer Specimen.

Serge J. Smeets, Albertus T. Hesselink, Ernst-Jan M. Speel, Annick Haesevoets, Peter J. F. Snijders, Michael Pawlita, Chris Jlm Meijer, Boudewijn J. M. Braakhuis, C. René Leemans, Ruud H. Brakenhoff
Published 2007 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Human papillomavirus type 16 (HPV16) plays a role in the development of a subgroup of head and neck squamous cell carcinomas (HNSCC). However, uncertainty exists about the true impact of HPV in this tumor type as conflicting reports have been published with prevalence rates from 0 to 100%. We aimed to find a detection algorithm of a biologically and thus clinically meaningful infection, applicable for high-throughput screening of frozen and formalin-fixed paraffin embedded (FFPE) specimens. By considering detection of HPV E6 oncogene expression in frozen biopsies as gold standard for a meaningful HPV infection, the value of several assays was evaluated on FFPE tumor specimens and sera of 48 HNSCC patients. The following assays were evaluated on FFPE tissue samples: HPV DNA general primer (GP)5+/6+ PCR, viral load analysis, HPV16 DNA FISH detection, HPV16 E6 mRNA RT-PCR, p16 immunostaining, and on corresponding serum samples detection of antibodies against the HPV16 proteins L1, E6 and E7. Comparing single assays on FFPE tissue samples detection of E6 expression by RT-PCR was superior, but application remains at present limited to HPV16 detection. Most suitable algorithm with 100% sensitivity and specificity appeared p16 immunostaining followed by GP5+/6+ PCR on the p16-positive cases. We show that clinically meaningful viral HPV infections can be more reliably measured in FFPE HNSCC samples in a standard and high throughput manner, paving the way for prognostic and experimental vaccination studies, regarding not only HNSCC, but possibly also cancer types with HPV involvement in subgroups such as penile and anal cancer.
This paper references
10.1002/ijc.10153
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
A L Combita (2002)
10.1056/NEJMoa065497
Case-control study of human papillomavirus and oropharyngeal cancer.
Gypsyamber D’souza (2007)
- expressing human papillomavirus
R Herrero (2006)
10.1002/ijc.21216
Feasibility of quantitative PCR-based saliva rinse screening of HPV for head and neck cancer.
Ming Zhao (2005)
10.1016/0304-419X(96)00020-0
Papillomavirus infections--a major cause of human cancers.
Harald Hausen (1996)
10.1128/jvi.67.3.1373-1384.1993
Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation.
Anne E. Griep (1993)
10.1200/JCO.2004.00.3335
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
Paul Maurice Weinberger (2006)
10.1056/NEJMoa021641
Epidemiologic classification of human papillomavirus types associated with cervical cancer.
Nubia Muñoz (2003)
10.1128/jvi.63.3.1441-1447.1989
Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms.
David Smotkin (1989)
10.1016/j.jcv.2005.05.006
Quantitative analysis of human papillomavirus type 16 in cervical neoplasm: a study in Chinese population.
Keith Wing-kit Lo (2005)
10.1128/JCM.43.9.4868-4871.2005
Comparison of Three Different PCR Methods for Quantifying Human Papillomavirus Type 16 DNA in Cervical Scrape Specimens
Albertus T. Hesselink (2005)
10.1002/ijc.1313
Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.
Viola M M van Houten (2001)
10.1158/1078-0432.CCR-05-0587
Tissue Distribution of Human Papillomavirus 16 DNA Integration in Patients with Tonsillar Carcinoma
Shahnaz Begum (2005)
10.1093/jnci/djg107
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Rolando Herrero (2003)
Genome - wide DNA copy number alterations in head and neck squamous cell carcinomas with or without
SJ Smeets
10.1136/jcp.44.12.990
Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation.
Kumarasen Cooper (1991)
10.1038/sj.bjc.6602436
High viral loads of human papillomavirus predict risk of invasive cervical carcinoma
Martin Moberg (2005)
10.1016/s1090-798x(08)70513-7
Vaccines against human papillomavirus and cervical cancer: promises and challenges.
Ali Mahdavi (2005)
10.1002/ijc.11389
A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
Harriet C Hafkamp (2003)
10.1016/S0002-9440(10)63871-0
Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus.
Jens Peter Klussmann (2003)
10.1002/jmv.20512
Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas.
Janine T. Bryan (2006)
10.1111/j.1600-0714.1997.tb00222.x
p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study.
Sabine Riethdorf (1997)
10.2307/2532320
Practical statistics for medical research
Douglas G. Altman (1990)
10.1128/JCM.40.3.779-787.2002
GP5+/6+ PCR followed by Reverse Line Blot Analysis Enables Rapid and High-Throughput Identification of Human Papillomavirus Genotypes
Adriaan J. C. van den Brule (2002)
10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
Jan M. M. Walboomers (1999)
10.1038/sj.onc.1208854
Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma
Christophe Rosty (2005)
10.1093/jnci/81.22.1698
Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer.
I. Jochmus-Kudielka (1989)
10.1086/346052
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
Raphael P. Viscidi (2003)
10.1200/JCO.2006.07.1829
Human papillomavirus and prognosis of oropharyngeal squamous cell carcinoma: implications for clinical research in head and neck cancers.
Maura L. Gillison (2006)
Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Maarten P. Tabor (2001)
10.1093/jnci/92.9.709
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
Maura L. Gillison (2000)
10.1158/1078-0432.CCR-05-2017
Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell Carcinoma
Robbert J. C. Slebos (2006)
10.1038/sj.onc.1205214
Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control
Tina Wiest (2002)
sistence of genetically altered fields in head and neck cancer patients : biological and clinical implications
MP Tabor (2001)
10.1158/1055-9965.EPI-04-0551
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
Aimée R Kreimer (2005)
10.1016/S0166-0934(02)00134-9
HPV antibody detection by ELISA with capsid protein L1 fused to glutathione S-transferase.
Peter Sehr (2002)
10.1158/0008-5472.CAN-04-3665
Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
Hester J T van Zeeburg (2005)
Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity.
Patrick K. Ha (2002)
10.1016/S0002-9440(10)63985-5
Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue.
Klaus Specht (2001)
10.1038/nrc798
Papillomaviruses and cancer: from basic studies to clinical application
Harald Hausen (2002)
10.1177/002215549704501013
Sensitive Multicolor Fluorescence In Situ Hybridization Using Catalyzed Reporter Deposition (CARD) Amplification
Ernst J. M. Speel (1997)
Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.
José Mario Sabio (2001)
10.1128/jcm.35.3.791-795.1997
A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.
Marcel V Jacobs (1997)
10.1093/jnci/djh179
Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients.
David I. Kutler (2003)
10.1086/381504
Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus.
Aimée R Kreimer (2004)
10.1093/jnci/djh183
Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
Boudewijn J. M. Braakhuis (2004)
10.1016/S0022-1759(01)00376-3
A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology.
Peter Sehr (2001)
10.1128/jcm.36.2.475-480.1998
Antibodies against Early Proteins of Human Papillomaviruses as Diagnostic Markers for Invasive Cervical Cancer
Wolfgang Meschede (1998)
10.1002/(SICI)1097-0142(19990501)85:9<1903::AID-CNCR4>3.0.CO;2-6
Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract.
J. Pintos (1999)
10.1002/ijc.10960
Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx.
Justine M. Ritchie (2003)
10.1038/sj.onc.1209275
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus
Serge J. Smeets (2006)
10.1002/ijc.11633
Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers.
Elaine M. Smith (2004)
10.1002/path.1433
The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity.
Peter J. F. Snijders (2003)
10.1002/1097-0215(20000520)89:3<300::AID-IJC14>3.0.CO;2-G
Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival.
Hanna Mellin (2000)



This paper is referenced by
10.1016/j.mrrev.2016.09.006
Human papillomaviruses in epigenetic regulations.
Julia Durzyńska (2017)
10.3109/00016489.2014.890289
High-risk HPV and survival in patients with oral and oropharyngeal squamous cell carcinoma – 5-year follow up of a population-based study
Karin Annertz (2014)
10.1007/s00405-015-3728-0
Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status
Annekatrin Coordes (2015)
10.1016/j.oraloncology.2014.05.004
Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas.
William H Westra (2014)
10.1016/S1632-3475(16)76086-3
Virus del papiloma humano y cáncer de orofaringe
Haitham Mirghani (2016)
10.1007/978-3-030-02200-6
Sexually Transmitted Infections: Advances in Understanding and Management
Antonio Cristaudo (2020)
10.1016/J.TVJL.2019.04.007
Increased p16CDKN2A, but not p53, immunostaining is predictive of longer survival time in cats with oral squamous cell carcinomas.
John S Munday (2019)
10.17863/CAM.31003
Genetic analyses, protein expression, type and function with clinical and immunological correlates in human papillomavirus associated head and neck neoplasia
Liam Masterson (2018)
CLINICAL IMPLICATIONS OF HPV IN OROPHARYNGEAL CANCER
To Caroline (2012)
10.1016/j.lfs.2018.09.033
Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status
Shanmei Du (2018)
10.3892/ijo.2014.2697
Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany.
Elgar Susanne Quabius (2015)
10.1002/hed.21714
High-risk human papillomavirus in nasopharyngeal carcinoma.
Aatur D Singhi (2012)
10.1111/j.1365-2559.2011.03805.x
Nuclear translocation of β-catenin and decreased expression of epithelial cadherin in human papillomavirus-positive tonsillar cancer: an early event in human papillomavirus-related tumour progression?
Markus Stenner (2011)
10.1201/B16389-16
Noninvasive Biomarkers in Head and Neck Squamous Cell Carcinoma
Vivek Srivastava (2014)
10.1016/j.oraloncology.2013.07.014
Identification of clinically relevant HPV-related HNSCC: in p16 should we trust?
Bohdan Wasylyk (2013)
10.1002/hed.23716
Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.
Rob Noorlag (2015)
10.3342/ceo.2012.5.4.207
The Prognostic Role of p16 Expression in Tonsil Cancer Treated by Either Surgery or Radiation
Tae Wook Kim (2012)
10.1007/s00405-012-2086-4
Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know
Eric M. Genden (2012)
10.3748/wjg.v20.i21.6632
Potential role of human papilloma virus in the pathogenesis of gastric cancer.
Miroslaw Snietura (2014)
10.1002/cncy.21372
Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
Darcy A. Kerr (2014)
10.1007/s00106-008-1867-y
Humane Papillomviren und Oropharynxkarzinome
Jens Peter Klussmann (2008)
10.1177/0300985814565133
Oral Papillomas Associated With Felis catus Papillomavirus Type 1 in 2 Domestic Cats
John S Munday (2015)
10.1158/1055-9965.EPI-10-1287
High-Risk Human Papillomavirus in Esophageal Squamous Cell Carcinoma—Response
Annika. Antonsson (2011)
10.1007/978-3-662-49651-0_7
Human Papilloma Virus as a Biomarker for Personalized Head and Neck Cancer Radiotherapy.
Jesper Grau Eriksen (2016)
10.14639/0392-100X-853
Human papillomavirus and head and neck carcinomas: focus on evidence in the babel of published data
Patrizia Morbini (2016)
10.1002/dc.23278
Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
Laleh Hakima (2015)
10.1053/j.semdp.2015.02.013
HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
Justin A. Bishop (2015)
10.1371/journal.pone.0122302
Association between P16INK4a Promoter Methylation and HNSCC: A Meta-Analysis of 21 Published Studies
Hao Shi (2015)
10.1007/978-1-4614-3970-7_47
Interpretation and Relevance of Advanced Technique Results
Charles W. Stratton (2012)
10.4132/KoreanJPathol.2012.46.2.177
Expression of Human Papillomavirus-Related Proteins and Its Clinical Implication in Tonsillar Squamous Cell Carcinoma
Joon Seon Song (2012)
10.4161/cc.24308
Potentially novel options for treatment of HPV-attributable head and neck cancer
Ruud H. Brakenhoff (2013)
10.1002/hed.23034
Viral load, physical status, and E6/E7 mRNA expression of human papillomavirus in head and neck squamous cell carcinoma.
Zeyi Deng (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar